Two biologics companies in South Carolina underwent FDA inspections during March, according to the U.S. Food and Drug Administration (FDA).
These inspections represented the second largest share by company type conducted by the FDA in South Carolina, accounting for 25% of all inspections that month.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 1 | — | — |
| Compliance: Devices | 1 | — | — |
| Foodborne Biological Hazards | 3 | 2 | — |
| Human Cellular, Tissue, and Gene Therapies | 1 | — | — |
| Postmarket Assurance: Devices | 1 | — | — |
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
